185 related articles for article (PubMed ID: 16437716)
1. Colon-specific drug delivery systems based on cyclodextrin prodrugs: in vivo evaluation of 5-aminosalicylic acid from its cyclodextrin conjugates.
Zou MJ; Cheng G; Okamoto H; Hao XH; An F; Cui FD; Danjo K
World J Gastroenterol; 2005 Dec; 11(47):7457-60. PubMed ID: 16437716
[TBL] [Abstract][Full Text] [Related]
2. Colon-specific drug delivery based on a cyclodextrin prodrug: release behavior of biphenylylacetic acid from its cyclodextrin conjugates in rat intestinal tracts after oral administration.
Minami K; Hirayama F; Uekama K
J Pharm Sci; 1998 Jun; 87(6):715-20. PubMed ID: 9607948
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and properties of polysaccharide prodrugs of 5-aminosalicylic acid as potential colon-specific delivery systems.
Zou M; Okamoto H; Cheng G; Hao X; Sun J; Cui F; Danjo K
Eur J Pharm Biopharm; 2005 Jan; 59(1):155-60. PubMed ID: 15567313
[TBL] [Abstract][Full Text] [Related]
4. Colon-specific delivery of prednisolone-appended alpha-cyclodextrin conjugate: alleviation of systemic side effect after oral administration.
Yano H; Hirayama F; Kamada M; Arima H; Uekama K
J Control Release; 2002 Feb; 79(1-3):103-12. PubMed ID: 11853922
[TBL] [Abstract][Full Text] [Related]
5. Colon-specific prodrugs of 5-aminosalicylic acid: synthesis and in vitro/in vivo properties of acidic amino acid derivatives of 5-aminosalicylic acid.
Jung YJ; Lee JS; Kim YM
J Pharm Sci; 2001 Nov; 90(11):1767-75. PubMed ID: 11745734
[TBL] [Abstract][Full Text] [Related]
6. 6A-O-[(4-biphenylyl)acetyl]-alpha-, -beta-, and -gamma-cyclodextrins and 6A-deoxy-6A-[[(4-biphenylyl)acetyl]amino]-alpha-, -beta-, and -gamma-cyclodextrins: potential prodrugs for colon-specific delivery.
Uekama K; Minami K; Hirayama F
J Med Chem; 1997 Aug; 40(17):2755-61. PubMed ID: 9276021
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis.
Jung Y; Kim HH; Kim H; Kong H; Choi B; Yang Y; Kim Y
Eur J Pharm Sci; 2006 May; 28(1-2):26-33. PubMed ID: 16455235
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro/in vivo evaluation of 5-aminosalicyl-glycine as a colon-specific prodrug of 5-aminosalicylic acid.
Jung YJ; Lee JS; Kim YM
J Pharm Sci; 2000 May; 89(5):594-602. PubMed ID: 10756325
[TBL] [Abstract][Full Text] [Related]
9. Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: synthesis, in vitro and in vivo assessment.
El-Kamel AH; Abdel-Aziz AA; Fatani AJ; El-Subbagh HI
Int J Pharm; 2008 Jun; 358(1-2):248-55. PubMed ID: 18502065
[TBL] [Abstract][Full Text] [Related]
10. Xylan from Pineapple Stem Waste: a Potential Biopolymer for Colonic Targeting of Anti-inflammatory Agent Mesalamine.
Anindya AL; Oktaviani RD; Praevina BR; Damayanti S; Kurniati NF; Riani C; Rachmawati H
AAPS PharmSciTech; 2019 Feb; 20(3):112. PubMed ID: 30761441
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and properties of 5-aminosalicyl-taurine as a colon-specific prodrug of 5-aminosalicylic acid.
Jung YJ; Kim HH; Kong HS; Kim YM
Arch Pharm Res; 2003 Apr; 26(4):264-9. PubMed ID: 12735682
[TBL] [Abstract][Full Text] [Related]
12. Cyclodextrin conjugate-based controlled release system: repeated- and prolonged-releases of ketoprofen after oral administration in rats.
Kamada M; Hirayama F; Udo K; Yano H; Arima H; Uekama K
J Control Release; 2002 Aug; 82(2-3):407-16. PubMed ID: 12175753
[TBL] [Abstract][Full Text] [Related]
13. In-vitro evaluation of biphenylyl acetic acid-beta-cyclodextrin conjugates as colon-targeting prodrugs: drug release behaviour in rat biological media.
Hirayama F; Minami K; Uekama K
J Pharm Pharmacol; 1996 Jan; 48(1):27-31. PubMed ID: 8722490
[TBL] [Abstract][Full Text] [Related]
14. Time- and pH-dependent colon-specific drug delivery for orally administered diclofenac sodium and 5-aminosalicylic acid.
Cheng G; An F; Zou MJ; Sun J; Hao XH; He YX
World J Gastroenterol; 2004 Jun; 10(12):1769-74. PubMed ID: 15188503
[TBL] [Abstract][Full Text] [Related]
15. Diclofenac-β-cyclodextrin for colonic drug targeting: In vivo performance in rats.
Vieira AC; Serra AC; Veiga FJ; Gonsalves AM; Basit AW; Murdan S
Int J Pharm; 2016 Mar; 500(1-2):366-70. PubMed ID: 26784980
[TBL] [Abstract][Full Text] [Related]
16. Biopharmaceutical evaluation of salicylazosulfanilic acid as a novel colon-targeted prodrug of 5-aminosalicylic acid.
Yamaguchi T; Sasaki K; Kurosaki Y; Nakayama T; Kimura T
J Drug Target; 1994; 2(2):123-31. PubMed ID: 7915179
[TBL] [Abstract][Full Text] [Related]
17. Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats.
Tozaki H; Odoriba T; Okada N; Fujita T; Terabe A; Suzuki T; Okabe S; Muranishi S; Yamamoto A
J Control Release; 2002 Jul; 82(1):51-61. PubMed ID: 12106976
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of modified beta-cyclodextrins on pharmacological activity and bioavailability of 4-biphenylacetic acid in rats after oral administration.
Puglisi G; Ventura CA; Spadaro A; Campana G; Spampinato S
J Pharm Pharmacol; 1995 Feb; 47(2):120-3. PubMed ID: 7602465
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and properties of dextran-5-aminosalicylic acid ester as a potential colon-specific prodrug of 5-aminosalicylic acid.
Jung YJ; Lee JS; Kim HH; Kim YT; Kim YM
Arch Pharm Res; 1998 Apr; 21(2):179-86. PubMed ID: 9875428
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of 5-aminosalicyl-glycine as a potential colon-specific prodrug of 5-aminosalicylic acid.
Jung YJ; Lee JS; Kim HH; Kim YM; Han SK
Arch Pharm Res; 1998 Apr; 21(2):174-8. PubMed ID: 9875427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
